Many doctors recommend that patients take a daily dose of aspirin to reduce their risk of heart attack or stroke. Now new research reported in the journal Cancer found that people taking aspirin or ibuprofen regularly were much more likely not to get deadly skin cancers.
But skin cancer is only the beginning of aspirin’s anti-cancer benefits. Three other recent studies, published in the Lancet, found that people who take a daily aspirin have as much as a 46% lower risk of colon, lung and prostate cancer compared with people who rarely or never take aspirin.
(READ the story in Forbes magazine)